Pegfilgrastim
Brand name: Neulasta
Rank #387 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$24.4M
Total Cost
3,096
Total Claims
$24.4M
Total Cost
102
Prescribers
$7,874
Cost per Claim
378
Beneficiaries
3,098
30-Day Fills
$239K
Avg Cost/Provider
30
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$24.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $24.4M total
🔎 Data Overview
At $7,874 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $238,996 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $64,491 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Pegfilgrastim
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Manish Dhawan | Hematology-Oncology | Minden, LA | 239 | $2.0M |
| 2 | Ashvini Sengar | Hematology-Oncology | Gadsden, AL | 106 | $903K |
| 3 | Ari Baron | Hematology-Oncology | San Francisco, CA | 108 | $741K |
| 4 | Antoine Chahine | Medical Oncology | Canfield, OH | 102 | $711K |
| 5 | Alyssa Sheridan | Physician Assistant | Morristown, NJ | 58 | $689K |
| 6 | Balagopalan Nair | Hematology-Oncology | Little Rock, AR | 92 | $632K |
| 7 | Brittany Gehm | Nurse Practitioner | Denville, NJ | 54 | $581K |
| 8 | Avi Retter | Hematology-Oncology | Bronx, NY | 73 | $513K |
| 9 | Noshir Dacosta | Medical Oncology | Smithtown, NY | 63 | $450K |
| 10 | John Graham | Hematology-Oncology | Canfield, OH | 63 | $430K |
| 11 | Phillip Reid | Hematology-Oncology | East Brunswick, NJ | 46 | $383K |
| 12 | Michael Sherman | Hematology-Oncology | Walnut Creek, CA | 54 | $374K |
| 13 | Nino Aleksidze | Hematology-Oncology | Montgomery, AL | 33 | $359K |
| 14 | Efat Azizi | Medical Oncology | Staten Island, NY | 53 | $355K |
| 15 | Richard Gordon | Hematology-Oncology | Voorhees, NJ | 50 | $337K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 384 | Pioglitazone Hcl (Pioglitazone Hcl) | $24.8M | 1,182,614 |
| 385 | Fremanezumab-Vfrm (Ajovy Autoinjector) | $24.7M | 29,389 |
| 386 | Nitrofurantoin Monohyd/M-Cryst (Nitrofurantoin Mono-Macro) | $24.4M | 1,173,249 |
| 387 | Pegfilgrastim (Neulasta) | $24.4M | 3,096 |
| 388 | Linagliptin/Metformin Hcl (Jentadueto) | $24.3M | 33,018 |
| 389 | Ocrelizumab (Ocrevus) | $24.2M | 639 |
| 390 | Fenofibrate (Fenofibrate) | $24.2M | 670,936 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology